Moleculin Biotech hosts virtual KOL event on soft tissue sarcoma lung metastases

Moleculin Biotech, Inc.

Hosted virtual KOL event on June 5, 2025, focused on soft tissue sarcoma lung metastases.
Key opinion leaders Kasper and Cherry participated and were compensated hourly for their time.
Presentation furnished as Exhibit 99.1; no material financial or clinical updates disclosed.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.